Women Health Diagnostics Market Size & Share, by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing); End-user (Hospitals, Clinics, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3844
  • Published Date: Sep 11, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Women Health Diagnostics Market size was valued at USD 18.63 billion in 2023 and is likely to cross USD 46 billion by the end of 2036, expanding at more than 7.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of women health diagnostics is assessed at USD 19.7 billion.

The growth of the market can be attributed to the rising awareness levels about various health disorders across the globe, and increasing prevalence of lifestyle and chronic diseases among women. According to the Pan American Health Organization, in 2019, a total of 534,242 deaths occurred due to chronic respiratory diseases in the region of the Americas alone, out of which 266,725, i.e., 50 percent deaths were among women. Along with these, growing occurrence of infectious disorders such as hepatitis and HIV in women all around the world is also expected to boost the growth of the market significantly in the forthcoming years. Furthermore, since the past few years, immunoassays, a highly popular platforms for diagnosing several conditions among women, are receiving surge in the number of regulatory approvals from medical bodies worldwide. This in turn is projected to offer ample growth opportunities to the market in the near future.


Women-Health-Diagnostics-Market
Get more information on this report: Request Free Sample PDF

Women Health Diagnostics Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Awareness Levels About Various Health Disorders Globally
  • Increasing Prevalence of Lifestyle and Chronic Diseases Among Women

Challenges

  • High Cost of Diagnostic Imaging Procedures and Systems

Women Health Diagnostics Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

7.2%

Base Year Market Size (2023)

USD 18.63 billion

Forecast Year Market Size (2036)

USD 46 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
 
Get more information on this report: Request Free Sample PDF

Women Health Diagnostics Segmentation

The women health diagnostics market is segmented by application into breast cancer, infectious disease testing, osteoporosis testing, pregnancy & fertility testing, sexually transmitted disease testing, and others. Out of these, the breast cancer segment is anticipated to hold the largest share in the global women’s health diagnostics market. This can be accounted to the increasing burden of breast cancer globally, and rise in investments in research and development for cancer diagnosis. Apart from these, provision of reimbursement and insurance coverage for breast cancer diagnosis in developed nations is also assessed to drive growth to the market segment in the future. Additionally, on the basis of end user, the home care segment is assessed to observe robust growth during the forecast period owing to the growing preference for using self-testing kits amongst women for various conditions, such as ovulation and pregnancy, as a result of their convenience of diagnosis. 

Our in-depth analysis of the global market includes the following segments

By Application

  • Breast Cancer
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy & Fertility Testing
  • Sexually Transmitted Disease Testing
  • Others

By End User

  • Hospitals
  • Clinics
  • Home Care

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Women Health Diagnostics Industry - Regional Synopsis

APAC Market Statistics

Regionally, the global women health diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is anticipated to hold largest revenue share by 2036, impelled by large patient pool, and surging improvements in the healthcare infrastructure.

North America Market Analysis

Moreover, the women health diagnostics market in North America is expected to grab the largest share during the forecast period, which can be credited primarily to the growing occurrence of cancer among women in the region. As per the National Cancer Institute, the rate of new cases of female breast cancer in the United States was 129.1 per 100,000 women per year. The rate is age-adjusted and based on 2014–2018 cases and 2015–2019 deaths. In addition, increasing demand for fertility test monitors, and high emphasis of pharmaceutical manufacturers on expanding their presence are also predicted to bolster the growth of the market in the region in the coming years.

Research Nester
Global-Women-Health-Diagnostics-Market
Get more information on this report: Request Free Sample PDF

Companies Dominating the Women Health Diagnostics Landscape

    • Siemens AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • F. Hoffmann-La Roche Ltd.
    • Cardinal Health, Inc.
    • General Electric Company
    • Hologic, Inc.
    • Becton, Dickinson and Company
    • Quest Diagnostics, Inc.
    • PerkinElmer Inc.
    • Alere Inc.
    • Biomérieux SA

In the News

  • August 2021- Siemens Healthineers and TeamViewer announced a partnership for enabling new digital models to combat the shortage of skilled radiology technologists in healthcare facilities.

  • September 2020- GE Healthcare unveiled Voluson SWIFT, an AI-enhanced women’s health ultrasound system with industry first auto recognition tools to improve efficiency.

Author Credits:  Radhika Pawar


  • Report ID: 3844
  • Published Date: Sep 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving market growth are rising awareness levels about various health disorders globally, and increasing prevalence of lifestyle and chronic diseases among women.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2022-2031.

High cost of diagnostic imaging procedures and systems is estimated to hamper the market growth.

Asia Pacific will provide more business opportunities for market growth owing to the large patient pool, and surging improvement of the healthcare infrastructure in the region.

The major players in the market are Siemens AG, F. Hoffmann-La Roche Ltd., Cardinal Health, Inc., General Electric Company, Hologic, Inc., and others.
Women Health Diagnostics Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample